
Covid is Airborne: You’re breathing it in
A powerful short video explaining how COVID spreads through the air like smoke, highlighting why ventilation, clean air and respiratory protection matter.
Report downloadable by clicking here.
A summary of the key findings is provided below. It is clear that Long Covid is impacting on the UK economy.
Prevalence & impact on daily life: Nearly 2 million people (≈3% of the UK population) live with Long Covid, with ~80% reporting reduced ability to carry out daily activities. Many are unable to work or live independently.
Long-term condition: Long Covid is now established as a chronic condition requiring long-term solutions. Current government funding for Long Covid clinics only extends to March 2025, with no guarantee of continued support.
Macroeconomic impact (baseline ~1.9m cases/year):
GDP loss: ~£1.5 billion annually
Employment loss: ~138,000 jobs
Household income loss: ~£1.3 billion annually
NHS treatment costs: ~£4.2 billion annually
If cases rise to 4m by 2030: GDP loss grows to £2.7bn, employment to −311,000, household income to −£2.1bn, and NHS costs to £9.3bn.
Health system strain: Managing Long Covid could require 46,000 additional healthcare workers, placing extra pressure on an NHS already struggling with waiting lists and underfunding. Without extra funding, other services may be cut.
Inequalities: Long Covid disproportionately affects lower-income groups, women, and people in retail/hospitality sectors, worsening social and economic inequality.
Wider impacts: The real burden is likely greater than measured GDP/job losses, as informal care costs, quality-of-life reductions, and disease burden (QALYs) are not fully captured.
Policy implications: Without action, Long Covid will act as a chronic drag on UK growth, health, and wellbeing. Addressing it requires sustained healthcare investment and policy choices, including exploring new taxation to fund long-term treatment and management.

A powerful short video explaining how COVID spreads through the air like smoke, highlighting why ventilation, clean air and respiratory protection matter.

Explore this SHH-UK Research Summary of a study examining patient-reported symptoms and treatment experiences among nearly 4,000 people with Long COVID and ME/CFS.

N95 and KN95 respirators may look similar, but they are certified to different national standards. Both are designed to provide a high level of filtration, with each rated to filter at least 95% of specified test particles. (Smart Air)